To clarify the role of TMPRSS2-ERG in prostate cancer, a TMA containing material from 350 prostate cancer patients whereof 256 were managed with watchful waiting, was analyzed with ERG immunohistochemistry (IHC). This evidence concerns the gene ERG and Familial prostate cancer.